Recherche
-
The impact of parent history of severe mental illness on schizophrenia outcomes: results from the real-world FACE-SZ cohort
(European archives of psychiatry and clinical neuroscience, 2022-07)Article de revue -
Recommendations of the schizophrenia expert center network for the screening prevention and treatment of sleep disorders based on the results from the real-world schizophrenia FACE-SZ national cohort
(Progress in Neuro-Psychopharmacology and Biological Psychiatry. vol. 110, 2021)Article de revue -
Recommendations of the treatment-resistant depression expert center network for promoting tobacco smoking cessation based on the results from the real-world FACE-TRD national cohort
(Progress in Neuro-Psychopharmacology and Biological Psychiatry. vol. 114, 2022-03)Article de revue -
Reward-related brain activity and behavior are associated with peripheral ghrelin levels in obesity
(Psychoneuroendocrinology. vol. 112, pp. 104520, 2020)Article de revue -
Clinical predictors of recurrences in bipolar disorders type 1 and 2: A FACE-BD longitudinal study
(Journal of Psychiatric Research. vol. 134, 2021)Article de revue -
Trajectories of medication adherence in patients with Bipolar Disorder along 2 years-follow-up
(Journal of Affective Disorders. vol. 282, pp. 812-819, 2021-03-01)Article de revue -
Comparison of three scales (BIS, SUMD and BCIS) for measuring insight dimensions and their evolution after one-year of follow-up: Findings from the FACE-SZ Cohort
(Psychiatry Research. vol. 303, 2021)Article de revue -
Childhood Trauma increases suicidal behaviour in a treatment-resistant depression population: a FACE-DR report
(Journal of Psychiatric Research. vol. 135, pp. 20-27, 2021)Article de revue -
A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials
(Molecular Psychiatry. vol. 27, n° 3, pp. 1286-1299, 2021-12)Article de revueLibre accès -
High S100B Levels Predict Antidepressant Response in Patients With Major Depression Even When Considering Inflammatory and Metabolic Markers
(International Journal of Neuropsychopharmacology. vol. 25, n° 6, pp. 468-478, 2022-02-17)Article de revueLibre accès